Abstracts tagged "Juvenile Arthritis"

Abstract Number: 2039 • 2012 ACR/ARHP Annual Meeting
Uveitis Surveillance Through Lean-Six Sigma for Quality Assurance in Juvenile Idiopathic Arthritis
Anjali Patwardhan¹, Kelly Kelleher², Jeffery Hoffman³, Karla B. Jones⁴, Stacy P. Ardoin⁵ and Charles H. Spencer⁶, ¹Pediatric Rheumatology, Nationwide Childrens Hospital, Columbus, OH, ²Pediatric Research and innovation, Nationwide Childrens Hospital, Columbus, OH, ³Emergency Medicine, Nationwide Childrens Hospital, Columbus, OH, ⁴Rheumatology ED260- 2S, Nationwide Children's Hospital, Columbus, OH, ⁵Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, ⁶Rheumatology, Nationwide Childrens Hospital, Columbus, OH
Background/Purpose: Chronic asymptomatic iridocyclitis occurs in 10-20% of all patients with JIA leading to insidious but progressive morbidity and possible blindness. Patients with JIA-associated uveitis…
Abstract Number: 2009 • 2012 ACR/ARHP Annual Meeting
Does Breastfeeding Influence the Presentation of Juvenile Idiopathic Arthritis? Results From the Childhood Arthritis Prospective Study
Hannah Pickford¹, Eileen Baildam², Alice Chieng³, Joyce Davidson⁴, Helen E. Foster⁵, Janet Gardner-Medwin⁴, Lucy R. Wedderburn⁶, Wendy Thomson¹ and Kimme L. Hyrich⁷, ¹University of Manchester, Arthritis Research UK Epidemiology Unit, Manchester, United Kingdom, ²Alder Hey Children's Foundation NHS Trust, Liverpool, United Kingdom, ³Manchester Children's Hospital, Manchester, United Kingdom, ⁴Royal Hospital for Sick Children, Glasgow, United Kingdom, ⁵Institute Cellular Medicine, Musculoskeletal Research Group, Newcastle upon Tyne, United Kingdom, ⁶Rheumatology Unit , Institute of Child Health, University College London (UCL), London, United Kingdom, ⁷Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit, Manchester, United Kingdom
Background/Purpose: There is extensive research into the association between breastfeeding (BF) and the occurrence of autoimmune diseases, although results have been conflicting. Studies have suggested…
Abstract Number: 1150 • 2012 ACR/ARHP Annual Meeting
Adverse Events in Juvenile Idiopathic Arthritis: Results From the Enhanced Drug Safety Surveillance (EDSS) Pilot Project
Sarah Ringold¹, Audrey F. Hendrickson², Carol A. Wallace³ and Rachel E. Sobel⁴, ¹Pediatrics, Seattle Children's Hospital/Univ of Washington, Seattle, WA, ²Rheumatology, Seattle Children's Research Institute, Seattle, WA, ³Pediatrics, Seattle Childrens Hospital, Seattle, WA, ⁴Epidemiology, Worldwide Safety Strategy, Pfizer, Inc., New York, NY
Background/Purpose: There are few data available regarding the rates of serious and important medical events (SAEs and IMEs) for most of the medications used to…
Abstract Number: 904 • 2012 ACR/ARHP Annual Meeting
Perinatal Characteristics, Maternal Reproductive History and Juvenile Idiopathic Arthritis: A Case-Control Study
Samantha W. Bell¹, Beth A. Mueller¹, J. Lee Nelson², Parveen Bhatti¹ and Susan Shenoi³, ¹Epidemiology and Public Health, University of Washington, Seattle, WA, ²Immunogenetics D2-100, Fred Hutchinson Cancer Rsch, Seattle, WA, ³Pediatric Rheumatology, Seattle Children's Hospital, University of Washington, Seattle, WA
Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is a heterogeneous group of chronic inflammatory arthritis conditions in children with onset before 16 years of age, and is the…
Abstract Number: 318 • 2012 ACR/ARHP Annual Meeting
Replication Analysis of Non-HLA Gene Variants with Prior Evidence of Association with Juvenile Idiopathic Arthritis
Justine Ellis¹, Raul Chavez², Anne-Louise Ponsonby², Angela Pezic², Roger Allen³, Jonathan Akikusa⁴ and Jane Munro⁵, ¹Murdoch Childrens Research Institute, Parkville, Australia, ²Environmental & Genetic Epidemiology Research, Murdoch Childrens Research Institute, Parkville, Australia, ³PRINTO, Genoa, Italy, ⁴Rheumatology, Royal Childrens Hospital, Parkville, Australia, ⁵Rheumatology, Royal Children's Hospital, Melbourne, Australia
Background/Purpose: Over the last few years, there have been numerous reports of associations of single nucleotide polymorphisms (SNPs) at various genetic loci with juvenile idiopathic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].